Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum

2000300 citationsJournal Article

Authors

Mark H. Whiteford

Heather M. Whiteford · Colon and Rectal Surgery Associates

Laurence F. Yee · Colon and Rectal Surgery Associates

Olagunju Ogunbiyi · Washington University in St. Louis

Farrokh Dehdashti · Mallinckrodt (Ireland)

Barry A. Siegel · Washington University in St. Louis

Elisa H. Birnbaum · Washington University in St. Louis

Abstract

2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography is more sensitive than computed tomography for the detection of metastatic or recurrent colorectal cancer and may improve clinical management in one-quarter of cases. However, 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography is not as sensitive in detecting mucinous adenocarcinoma, possibly because of the relative hypocellularity of these tumors.

Topics & Keywords

Medical Imaging Techniques and Applications Radiomics and Machine Learning in Medical Imaging Pancreatic and Hepatic Oncology Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diseases of the Colon & Rectum

Volume 43, Issue 6, pp. 759-767

DOI: 10.1007/bf02238010

Field-Weighted Citation Impact: 15.15